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1. Introduction 
All life on earth has evolved in, and via the adaption to, the presence of gravity. This includes 
humans who branched off from a distant ancestor about five to seven million years ago. On 
April 12, 1961, one such human---Yuri Gagarin of the Soviet Union---took off in Vostok 3KA 
for the first trip into outer space. Since then, numerous trips to the moon, the Skylab, and 
within the Space Shuttle have followed. With the recent completion of the International Space 
Station, the current focus is set on very long duration crewed missions to the station, the 
establishment of a potential lunar outpost, and possible exploration of Mars.  
As more and more humans head to space for longer and longer periods of time---out of 
desire or necessity---significant challenges will be faced. The technological challenges will 
undoubtedly be met. The past fifty years have taught us that given adequate time and 
financial resources nearly any technological hurdle can be jumped. The biological challenges 
are far greater. As noted, all human life on earth has evolved via adaption to gravity and 
long-term exposure to microgravity takes its toll; especially on the musculoskeletal, 
cardiovascular, sensory-motor, and immune systems. 
In this chapter, we will review the known effects of long-term microgravity on the skeletal 
system, examine what is as-yet unknown, and explore possible interventions that might be 
used to address these effects. 
2. The impact of microgravity at the cellular level 
2.1 Osteoporosis on earth 
Osteoporosis occurring on earth in the presence of normal gravity is most often associated 
with aging and most significantly impacted by peak bone mass and the rate of bone loss 
thereafter. Peak bone mass is generally achieved while humans are in their early thirties and 
subsequent bone loss is impacted not only by aging and menopause (women), but by 
hereditary predispositions, exogenous factors (such as alcohol, smoking, inactivity, 
malnutrition, prescription medications, etc.), and disease states (such as endocrine 
disorders, renal disorders, rheumatologic disorders, etc.). Each of these causes results in a 
final common pathway leading to osteoporosis---an imbalance between bone formation and 
bone resorption. Fractures, primarily of the proximal femur (‘hip’), vertebral bodies, and 
distal radius (‘wrist’) are significant risks and, as other chapters in this text have outlined, 




Osteoblast and osteoclast uncoupling is the primary source of this excessive resorption and 
biomechanical fragility of bone. If the cause can be determined, then reasonable solutions 
aimed at such uncoupling can be offered to address the problem. Bispohosphonates and, 
more primitively phosphate, can impede osteoclastic resorption. Calcium, Vitamin D, 
calcitonin, estrogen, exercise, smoking and alcohol restriction, and avoidance of particular 
medications can help halt bone loss. Fluoride (no longer used), parathytoid hormone, and 
aggressive exercise might result in bone mass gain. 
2.2 Osteoporosis in microgravity 
Osteoporosis occurring as a result of microgravity is, from the perspective of the organism 
down to the lowest biological level, different than that encountered on earth. 
2.2.1 Cytoskeletal alterations 
Microgravity appears to significantly alter the cellular cytoskeleton. Proper cytoskeletal 
structure allows intracellular proteins to participate in important functions such as mitosis, 
cell motility, intracellular transport, and organization of organelles. Actin filaments, 
intermediate filaments, and microtubules are the key elements and they serve as a highly 
organized dynamic scaffold on which intracellular processes take place. 
In microgravity, cellular structure, intracellular organization, and micro-fluid dynamics are 
altered[1]. Disruption of normal biochemical and physiological processes follows. Clement 
and Slenzka[2] have demonstrated that the spatial relationships between cellular organelles 
and structures are abnormal. And He[3] and Crawford-Young[4] have demonstrated that 
cellular cytoskeletal and microfilament dynamics are anomalous and might well be the 
source. Thus DNA replication, RNA transcription, protein migration, and ionic and 
molecular transport are perturbed.  
2.2.2 Mesenchymal stem cells 
The impact of these intracellular changes is felt by mesenchymal stem cells (MSC). MSC---
present in adult life in the periosteum of bones and within the bone marrow---differentiate 
into osteoblasts following appropriate signaling and presence within the proper mileau. 
Meyers[5], Yuge[6], Huang[7], and Pan[8] (in separate studies) have demonstrated via flow 
cytometry, transcriptional analyses, and proteomic analyses that MSCs ability to proliferate, 
to differentiate into osteoblasts, and to contribute to osteogenesis is inhibited by 
microgravity. 
2.2.3 Osteoblasts 
Osteoblasts are also directly compromised. Bucaro[9] has demonstrated findings that 
suggest that direct induction of osteoblast apoptosis occurs in microgravity. Apoptosis is 
differentiated from usual cell necrosis (where cells swell, burst and die) by characteristic 
intracellular changes including nuclear condensation and shrinkage and cytoplasmic 
vacuolization. Observed osteoblastic apoptosis likely results from cytoskeletal changes.  
Additionally, Colleran[10] has noted that the cephallic fluid shift experienced by humans in 
microgravity might alter interstitial fluid pressures and flows and, given that osteoblasts 
survive somewhat tenuously in low flow areas, these shifts might result in cell functional 
compromise or death. 
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3. The impact of microgravity at the systemic level 
Systemically, microgravity induces osteoporosis via the above noted unique cellular 
changes coupled with an environment of nearly non-existent mechanical stresses where 
normal weight-bearing and the normal response of bone to proliferate accordingly (Wolff’s 
Law) is altered. And this alteration differs than, say, that seen with immobilization. While 
patients placed in body casts and on bed rest (fully non-weightbearing) will suffer from 
osteoporortic changes, the amount of calcified bony tissue lost over three months is 
generally about 3%, tends to then level off at about three months (no further loss), and tends 
to be reversed with resumption of weight-bearing. In microgravity, the loss occurs at four 
times the rate, does not appear to level off, and appears to be much less reversible. Thus, the 
one-year trip to Mars is estimated to potentially result in a (devastating) greater than 25% 
reduction of bone mass. And this is in astronauts; predominantly male, at an age where their 
bone mass is at peak levels, exposed to no exogenous factors (smoking, excessive alcohol, 
etc.), in prime physical condition, and with no underlying disease states. 
Simply, the combination of altered cellular form and function coupled with differences in 
bony response to microgravity systemically means that this form of osteoporosis bears 
relatively little relation to that seen on earth and that astronauts experience early, 
aggressive, continual bone loss. Predictably, systemic markers of bone resorption are greatly 
increased, while markers of bone formation are decreased[11] to levels rarely seen in on-
earth conditions. And, importantly, it is unclear whether these changes are fully reversible 
upon return to earth and ‘normal’ gravity conditions. 
4. Bone health and present day human spaceflight 
Since the earliest days of human spaceflight, physiologists and NASA flight surgeons 
recognized the importance of exercise to maintain musculoskeletal and cardiovascular 
health. Owing to prolonged exposure to microgravity, Astronaut crews returning from 
America’s first space station, Skylab, were too weak to stand upon return to earth. Exercise 
equipment thus became a requirement for all long duration space missions. A series of 
devices, including treadmills, stationary bicycles, rowing ergometers, simple resistive 
exercise systems and complex, reconfigurable “weight machines” have evolved in the years 
since, both in the Soviet-turned-Russian space program and now in the US-led International 
Space Station (ISS) program. 
Exercise devices designed to maintain cardiovascular fitness in the absence of gravity 
proved to be a more straightforward engineering goal: movement against a friction wheel 
can easily challenge the cardiopulmonary system. Providing resistive exercise challenge to 
the postural musculoskeletal system of sufficient intensity and quality has only recently 
been accomplished aboard the ISS. The Advanced Resistive Exercise Device (ARED) uses 
pistons to provide smooth exercise loads, and is highly reconfigurable for a wide array of 
concentric and eccentric exercises. 
The world record duration in space is held by Dr. Valeri Polyakov, who spent 437 
consecutive days in microgravity, landing in 1995. During his endurance mission he was 
required to exercise up to four hours a day. Human spaceflight is very costly, but is 
obviously undertaken to accomplish important scientific goals in life sciences, material 
science, fluid and combustion physics, global environmental monitoring and many other 




today, the overhead of spending up to two hours each and every day in space for the sole 
purpose of exercise is problematic.  
ISS crewmembers actively work with strength and conditioning coaches throughout their 
preflight training. Using exercise monitoring hardware aboard ISS, these same coaches 
perform inflight assessments of the crew’s conditioning while they are in space, and make 
exercise prescription modifications from Mission Control Houston, as required.  Additionally, 
they oversee the crew’s postflight physical rehabilitation, a process which may take several 
months to restore bone density to critical areas such as the hip and lumbar vertebral bodies. 
Armed with an understanding of the whole body, cellular and subcellular processes 
involved in bone density maintenance in altered gravitational fields, more effective and 
efficient means to preserve musculoskeletal health is necessary to send humans beyond 
short stays aboard the ISS: Lunar outposts and expeditions to Mars are even more 
committing endeavors, and warrant substantial attention. 
5. Future directions for research 
Despite a reasonable foundation of information, much work is needed to further delineate 
the impact of microgravity on bones at the cellular and systemic levels. Clearly the best 
strategy is to conduct experimental in-vivo human studies in space, but limited access to 
spaceflights and limited time during flight available to dedicate to these studies renders 
extensive (but necessary) study unachievable[1]. Accordingly, microgravity simulation has 
been the primary source of basic biological scientific information including most of what has 
been discussed thus far in this chapter. 
On the celular level, simulation can be carried out within the rotating-wall vessel (RWV); a 
NASA-designed tissue culture bioreactor which simulates microgravity[1]. The bioreactor 
rotates horizontally such that, at an ideal speed, the contents achieve relative suspension 
simulating microgravity via dynamic equalibrium of forces---the contained cells / tissues 
remain in a state of long-term, suspended free-fall. The cells / tissues retain viability by 
being contained along with cell-specific growth media and oxygenation via active or passive 
diffusion provided by a silicon rubber membrane. To date however, relatively few studies 
have been carried out and there is significant need for further study on the cellular level as 
this level may be the key to differences relative to earthly osteoporosis. Additionally, 
comparison with studies performed in space will be required to validate the model and to 
ensure that changes noted are not unique to the system itself---in-vitro cellular behavior 
does not always mirror real life. 
On the system / organism level, research has focused on animal models; most commonly 
hind-limb unloading and head-down bed rest (which has also been used in human 
volunteer subjects)[1]. While such models provide some insight into rapid bone loss, they 
are not fully satisfactory given that they fail to incite the noted cellular changes associated 
with microgravity and gravitational forces still compress bodily tissues whereas, in true 
microgravity, there is negative pressure experienced by tissues. It is clear that better models 
need to be developed. 
6. Potential future options for treatment and prevention 
Current options for the prevention and treatment of osteoporosis have proven far more 
successful on earth than in microgravity and this is likely commensurate with the above 
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noted cellular anomalies encountered. Aggressive exercise by astronauts---recommended at 
two hours per day of heavy resistance work---has made an impact; however, freeing up time 
for such activities is difficult given the operational needs during missions and, as space flight 
expands generally, the baseline cardiovascular capabilities of travelers will be more limited. 
Additionally, the aforementioned cellular changes render supplements (Calcium, vitamin D, 
etc.), medications (bisphosphonates, etc.) and hormones (testosterone, etc.) significantly less 
effective in astronauts despite having a minor effect in microgravity animal models. 
6.1 Diagnostic platforms 
The identification of new diagnostic or prognostic biomarkers has been gaining attention in 
the field of bone disease research leading to significant benefits in terms of efficient and 
timely treatment. Clearly novel strategies will need to be developed, and directed both at 
the molecular / cellular and bony systemic levels, and will need to be long lasting and 
simple to administer.  In our minds, the ideal platform for the development of such novel 
strategies will rest upon nanotechnology. The size of nanomaterials mirrors that of most 
biological molecules and structures allowing size-matched communication and intervention 
important in diagnostics and therapeutics at the sub-cellular level and felt to be the source of 
bone cell dysfunction in microgravity.  
In this context, particular emphasis is placed on study of circulating proteome. The 
proteome represent the functional picture of the state of the cells because it constantly 
changes through its biochemical interactions with the genome and the environment. Protein 
turnovers and tissue microenvironment create a rich and heterogenic circulating mixture of 
protein fragments (low molecular weight peptidome, LMWP) that reflects both 
physiological and pathological processes. Despite its potential in clinical applications, 
profiling of the LMWP has proven to be a significant technical challenge because of the 
extremely high dynamic range of protein concentrations in blood and body fluids. 
Development of technologies that enable controlled fabrication of structure with nanoscale 
dimension can address the issues of the intrinsic complexity of the circulating low molecular 
weight peptidome [12,13]. Our group has developed diagnostic nanochannel-based lab-on-
a-chip technologies [Fig 1] that can allow for the detection of the earliest signs of disease, 
including osteoporosis, using penny-sized discs (satisfying the need for space preservation 
during space flight). This device is a size-exclusion method based on mesoporous silica thin 
film chips able to rapidly fractionate, and selectively enrich and protect peptides and 
proteins from enzymatic degradation. The mesoporous silica chip were produced by the 
evaporation-induced self –assembly procedure under acidic conditions using triblock 
copolymers as structural templates [14,15].  
Physical properties of mesoporous silica such as pore dimension, pore texture, and chemical 
surface properties such as charge and further functionalization with selective ligands can be 
easily controlled and tuned to enhance the ability to detect traces of molecules. The ability to 
fabricate nanoscale devices and materials with a high degree of precision and accuracy, in 
combination with the recent advances in mass spectrometry, resulted in a powerful 
proteomic nanoscale platform for early disease diagnosis [16]. These lab-on-a-chip based 
diagnostic technologies can be either used as external devices or be implanted in the body of 
the astronaut.  Implantable chips can feature molecularly driven sensors able to measure 
vital signs and readily respond to specific variation by releasing counteracting molecules. 




the efficacy of therapeutic interventions. In their most complex configuration these 
implantable devices can be considered as artificial glands that sense the status of the body 
and adjust to it trying to bring back homeostasis. Nanotechnology based diagnostics offer 
higher detection capabilities due to the reduction of the size of the sensors, the increase of 
their sensitivity, the absence of non-specific reactions, and the multiplexing of the multi-
scale detectors that allow a wide range of intensities of the signal to be measured. 
 
 
a-h, Schematic evolution of the chemical composition of the coating solution during the production of a 
mesoporous silica film. a, Fresh coating solution; b, Formation of micelles; c, Evaporation induced self 
assembly during spin-coating process; d, Zoomed in view of a pore after aging at elevated temperature. 
e, Bulk silicon wafer surface; f, Mesoporous silica film on a bulk silicon wafer. e-f, Cross-section of GX6 
chip by SEM and TEM imaging respectively (scale bar is 500nm). i-n, images of the different chip 
surfaces and of the different masks that define the spotting areas.  
Fig. 1. Production and assembly of MSC for proteomic applications 
6.2 Delivery systems 
We developed novel silicon-based theranostic nanoparticles [17-19] that have been used to 
achieve long-term, controlled, and targeted release of proteins and drugs that help halting or 
reversing osteoporosis. Among the molecules tested bone morphogenetic proteins (BMPs---
which are differentiation factors that facilitate the transition of mesenchymal stem cells to 
osteoblasts thereby encouraging bone formation) and bisphosphonates (which inhibit 
osteoclasts mediated bone resorption). The finely-tuned, extended, local delivery allowed by 
the use of these particles means that a single treatment can be administered pre-flight with 
effects felt for months on end (no need to ‘re-dose’) and might prove to prevent or treat 
osteoporosis of microgravity. Nanoporous silica and PLGA composites are capable of 
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releasing molecules in a burst or steady fashion over the course of days, weeks, or even 
months. These systems can also be tuned to release their payload in response to environmental 
stimuli (pH, temperature, blood concentrations, exposure to radiation, bone degeneration, 
etc.). The local delivery of antibiotics, dexamethasone, and growth factors (BMP-2) to the bone 
defect areas by PLGA/pSi microspheres reduced inflammation and stimulated new bone 
formation whilke simultaneously fighting bacterial growth. A wide variety of therapeutic and 
imaging agents have been successfully loaded into and released from pSi particles such as 
steroids [21], hormones [22], proteins[23], cancer drugs [24], or even secondary drug delivery 
vehicles including iron oxide nanoparticles [25], quantum dots, liposomes [26] and carbon 
nanotubes loaded with therapeutic drugs[18,27] to the diseased areas. In order to achieve the 
level of control on the release dynamics, it is possible to tailor both the pore size of the pSi 
during particles’ fabrication or vary polymer type, molecular weight and density. Finally, the 
overall size of the polymer/pSi composites can also be tuned from nano level to micro level to 
suit certain applications by changing the polymer concentration, surfactant concentration, or 
the stirring speed. This hybrid system not only can reduce or abolish burst release, and 
prolong release kinetics, but also protect biomolecules from denaturation both during the drug 
loading process and while implanted in vivo. These particles have been successfully tested in 
different orthopedic tissue engineering applications in small and large animal models of bone 
fracture repair (manuscripts in preparation). 
 
 
Fig. 2. Scanning electron microscopy (SEM) images of pSi particles reveals (A) uniform 
shape and size of particles, (B) the pore structure on the surface of the particles, and the (C) 








Fig. 3. Release profiles of FITC-BSA from various examined PLGA/pSi microsphere 
formulations. (A) Total FITC-BSA released over 27 days, (B) first three day release. 
6.3 Injectable materials 
Beyond these diagnostic and drug-delivery applications, our group has also developed 
injectable gels that employ nanotechnologies to deliver mesenchymal stem cells, platelet rich 
plasma, and osteogeneic factors directly to areas of bony weakness. Thus, astronauts 
identified to have focal osteoporosis of, say, the proximal femur, might be treated by simple 
focal injection affording the in-vivo, in-situ rapid regeneration of lost bony mass.  
These composites have proved their osteogenic capacity in vitro and through in vivo 
subcutaneous implants where ectopic bone was formed. The use of bio-porogens 
synthesized from natural and biodegradable materials, encourages bone formation and 
vascularization in vivo. These porogens particles house and release MSC, recruit 
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[28].  They also exhibit tremendous viability of MSC after cryo-preservation, allowing for 
long-term storage of prepared bio-porogens for immediate “on-demand” use in the clinic. 
Previously, we found that MSC isolated from compact bone (CB) tissue were more frequent 
in the total cell population and of greater colony-forming and tri-lineage differentiation 





Fig. 4. MSC from compact bone (CB) produce larger and more defined colonies than those 
from bone marrow (BM) (A). The incidence of MSC from bulk cell populations is also nearly 
10x higher in CB than BM (B). 
All these biomaterials were based on the unique combination of I) nanostructured 
biomaterials able to mimic the extracellular matrices of either bone or cartilage with II) 
chemical and biochemical cues able to direct, control and preserve the phenotypes of both 
osteoblasts in their histological compartments. These biomaterials are made available as 
injectable hydrogel formulations thus reducing surgical invasiveness and improving the 
accuracy of the delivery to the targeted anatomical sites. Injectable composite 
hydrogels/pastes can be used for the spinal regions weakened by OP, with appropriate 
biomimetic and biomechanical characteristics.  
These biomaterials can be functionalized and/or doped with chemical (e.g. strontium ions, 




genes) agents able to control cell phenotype and activity. Hydrogel formulations to be 
examined include collagen, gelatin, alginate, self-assembling peptides, or combinations 
thereof. The nano-features include peptides that bind to integral growth factors such as 
BMP-2 and VEGF and PRP. The scaffolds may be co-implanted with mesenchymal stem 
cells obtained from bone marrow and adipose aspirates. Finally, we have developed ways to 
reinforce biocompatible polymers with nanoparticles / nanowires that greatly increase their 
strength allowing for the replacement of bulky, heavy metallic devices currently used for 
fracture repair---the light-weight, injectable polymers ideal for transport on space flights and 
use for the repair of osteoporotic fractures once they occur. 
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